Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for publishing professionals · Sunday, January 26, 2020 · 508,075,890 Articles · 3+ Million Readers

Tauriga Sciences, Inc. to Present this Morning at the Fall Investor Summit 2019 at 9:00 a.m. EST at The Essex House Hotel in Midtown Manhattan

/EIN News/ -- NEW YORK, NY, Sept. 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that it will be presenting at the Fall Investor Summit 2019 (“The MicroCap Conference”) this morning (September 16, 2019) at 9:00 a.m. EST at The Essex House Hotel in Midtown Manhattan - New York City. 

Fall Investor Summit 2019 Conference Link:

Presenting on behalf of Tauriga Sciences, Inc. will be its Chief Executive Officer, Mr. Seth M. Shaw.  

The Company plans to present at a number of investor conferences, both domestic and international, over the course of the remainder of 2019 and 2020. The Company believes that its flagship product Tauri-Gum™ (CBD Infused chewing gum) may represent a high quality/low risk opportunity for potential customers to enter the CBD Edibles space. The Company is actively selling two distinct flavors, Mint and Blood Orange, and is expecting to roll out new product(s) in the near term.


Tauriga Sciences, Inc. (TAUG) is a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities. One such opportunity on which the Company has acted, involves the Company having entered into the cannabidiol (or “CBD”) infused chewing gum product business, as more fully described above and in prior press releases. This CBD infused chewing gum product has been branded under the following name: Tauri-Gum™.  See also our periodic reports filed by us with the SEC for a more complete description of our business and material agreements that we have entered into. Further, the Company continues to identify and evaluate additional potential opportunities to generate revenue, as well as shareholder value, and leverage its resources and expertise to build a diversified and sustainable business model. Please visit our corporate website at

In addition, on March 11, 2019, the Company announced the official launch of its E-Commerce site - as part of its Tauri-Gum™ commercialization strategy. This site can be accessed by visiting the following URL address:

The Company has established corporate offices in both New York City (USA) and Barcelona (Spain). 

DISCLAIMER -- Forward-Looking Statements

This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.

                    Tauriga Sciences, Inc.
                    555 Madison Avenue, 5th Floor
                    New York, NY  10022
                    Chief Executive Officer
                    Mr. Seth M. Shaw
                    Cell # (917) 796 9926
                    Corp. Website:
                    E-Commerce Website: 

Primary Logo

Powered by EIN News
Distribution channels: Healthcare & Pharmaceuticals Industry

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release